Market Overview The hemophagocytic lymphohistiocytosis treatment market is advancing through targeted biologics that address specific cytokine drivers of hyperinflammation, offering alternatives to the cytotoxic chemotherapy traditionally required for disease control. These precision approaches aim to suppress pathological immune activation while preserving sufficient immunity to prevent...